Day 1 – Wednesday 26th March 2025
Times in GMT, Dublin please add one hour for Central European time

9.00h GMT

Welcome and Introductions
Dr Irene McGrath
Managing Director, Kerona Scientific Ltd., Ireland

9.10 – 9.35

EU Biocide Developments – An Irish Perspective
Dr Mervyn Parr
Risk Manager, Pesticide Registration and Control Division, DAFM, Ireland

9.35 – 9.40

Question and answer session

9.40 – 10.05

Update on the situation with Biocide Regulation in GB

Zameer Bhunnoo

Biocides Policy Advisor, Health and Safety Executive, GB

10.05 – 10.10

Question and answer session

10.10 – 10.30

Coffee Break

10.30 – 10.55

Monitoring of an experimental project related to a BPR Family

Dr Francesca Fasano
Operation Director, Chemsafe Srl, Italy

10.55 – 11.00

Question and answer session

11.00 – 11.25

Analysis of Alternatives
Martijn van Velthoven and Annemarie Haasnoot

Rules4Regulatory, Netherlands

11.25 – 11.30

Question and answer session

11.30 – 11.55

Developments in US Antimicrobial Registration
Seth Goldberg
Lawyer and Shareholder of Greenberg Traurig, LLP, Washington

11.55 –12.00

Question and answer session

12.00h

Closing remarks from Day 1

Day 2 – Thursday 27th March 2025
Times in GMT, Dublin please add one hour for Central European time

9.00h GMT

Welcome and Introductions
Dr Irene McGrath
Managing Director, Kerona Scientific Ltd., Ireland

9.10 – 9.35

Current BPC Activities
Dr Joost van Galen
Chair Biocidal Products Committee, Directorate Risk Management, ECHA, Finland
 

9.35 – 9.40

Question and answer session

9.40 – 10.05

BPR in 2025: What can product formulators expect? Perspective from the cleaning and hygiene products industry
Elodie Cazelle
Senior Scientific and Regulatory Affairs Manager at International Association for Soaps, Detergents and Maintenance Products (A.I.S.E.), Belgium

10.05 – 10.10

Question and answer session

10.10 – 10.30

Coffee Break

10.30 – 10.55

Expiry of Data Protection for the Review Data for existing AS

Darren Abrahams
Partner/Barrister and Avocat, Steptoe and Johnson LLP, Belgium

10.55 – 11.00

Question and answer session

11.00 – 11.25

Update on the state of play of implementation of the BPR

Ligia Negulici
European Commission

11.25 – 11.30

Question and answer session

11.30 – 11.45

Additional time allowed for Q&A (if required

11.45 –12.00

Closing remarks from Day 2